Connect with us
NNPA NEWSWIRE — The agreement covers co-development and co-commercialization aimed at accelerating the development of BioNTech’s potential first-in-class COVID-19 mRNA vaccine program, BNT162, which is expected...
NNPA NEWSWIRE — As you may have heard, my team at Pfizer recently experienced a significant disappointment. Our phase 3 trial for rivipansel, a potential treatment...
NNPA NEWSWIRE — “I want people who are going to be able to tell it straight. People who will assess a situation and then be able...
NNPA NEWSWIRE — "If we are going to prepare our country's youth for their future properly, we must ensure that we are giving them the fundamental...
NNPA NEWSWIRE — Marie Ojiambo, who graduated from St. John’s University’s College of Pharmacy and Health Sciences in New York and who specializes in pre-clinical Pharmaceutical...
ROLLINGOUT.COM — Women of Power Summit is one of the top business events in America.
NNPA NEWSWIRE — Her Excellency, Dr. Arikana Chihombori-Quao, the African Union Ambassador to the United States, also appeared at the conference where she and Jamaican Tourist...
NNPA NEWSWIRE — Research indicates that as many as 3 million Americans carry the sickle cell trait, primarily impacting African Americans. In fact, nearly 1 in...
(Tech Times) – Pfizer’s breast cancer drug Ibrance shows favorable clinical trial after facing delays due to efficacy issues. Ibrance is also well-known as palbociclib...
